Vantiv, Inc. (VNTV)declared financial results for the second quarter ended June 30, 2015. Revenue augmented 29% to $786.0 million in the second quarter as compared to $608.7 million in the previous year period. Net revenue augmented 28% to $423.6 million in the second quarter as compared to $331.3 million in the previous year period, primarily due to strong growth in Vantiv Merchant Services segment. On a GAAP basis, net income (loss) attributable to Vantiv, Inc. was $36.5 million or $0.24 per diluted share in the second quarter as compared to ($1.4) million or ($0.01) per diluted share in the prior year period.
Vantiv Inc (NYSE:VNTV) reported the surge of 0.89% and closed at $43.15, with the total traded volume of 3.09 million shares and opening price was $42.88. During last trade its minimum price was $42.51 and it gained its highest price of $43.36 and has a total of 146.18 million outstanding shares and its total market capitalization is $8.08 billion.
National Oilwell Varco, Inc. (NOV)unveiled that for its second quarter ended June 30, 2015, it earned net income of $289 million, or $0.74 per fully diluted share, compared to first quarter ended March 31, 2015 net income of $310 million, or $0.76 per fully diluted share. Excluding other items and non-recurring charges from all periods, second quarter net income was $301 million, or $0.77 per fully diluted share, compared to $1.14 in the first quarter of 2015 and $1.47 in the second quarter of 2014.
National-Oilwell Varco, Inc. (NYSE:NOV) started its trading session with the price of $43.87 and closed at $43.41 by scoring -1.09% and traded with total volume of 3.64 million shares, while the average trading remained 5.59 million shares. During last trade its minimum price was $43.06 and it gained the highest price of $44.12. Its market capitalization was $17.02 billion.
GSK (NYSE:GSK)declared it has begun shipping FLUARIX® QUADRIVALENT (Influenza Vaccine) doses to US healthcare providers, subsequent licensing and lot-release approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research.
GlaxoSmithKline plc (ADR) (NYSE:GSK) showing jumped of 2.28% and closed at $43.59, after gaining total volume of 7.69 million shares. Its opening price was $43.27. Its earnings per share(EPS) is $6.58 and its beta value stands at 0.67 points and has total market capitalization of $104.41 billion and a total of 5.31 bmillion outstanding shares.
The Bank of New York Mellon Corporation (BK), an investment company, provides financial products and services to institutions, corporations, and high net worth individuals in the United States and internationally. It functions through two sections, Investment Management and Investment Services. The company offers investment management; trust and custody; foreign exchange; fund administration; global collateral services; securities lending; depositary receipts; corporate trust; global payment/cash management; banking services; and clearing services.
Bank of New York Mellon Corp (NYSE:BK) reported the surge of 0.73%, after closing price for the day was $43.93 and opening at the price of $43.61. Its total trading volume for the day was 4.73 million shares, versus its average volume of 5.44 million shares. Its earnings per share are $2.53.